News
NMN Lowers Blood Pressure in Patients with Hypertension: Latest Human Trial
Unlocking the Potential of NMN: A Promising Breakthrough in Hypertension Treatment High blood pressure, or hypertension, is a looming menace that has been and is affecting millions of people in India and across the globe. It's surprising to learn that even the younger generation, aged 15 to 49, is grappling with this health issue, thanks to their hectic and stressful lifestyles. In India, the numbers are staggering, with approximately 234 million people dealing with high blood pressure. But there's hope on the horizon, and it comes in the form of NMN. The Subdued Onslaught of Hypertension in India The surge of hypertension has emerged as a prevailing contributor to cardiovascular ailments in India, exerting its influence on approximately 30% of the adult population. What is undeniably disquieting is its pivotal role in contributing to nearly 63% of the overall mortalities within the nation, with a substantial 27% ascribed directly to cardiac complications. However, the truly astonishing facet of this dilemma lies in the revelation that an overwhelming 45% of individuals aged 40 to 69 in India grapple with cardiovascular disorders. This pervasive prevalence of hypertension could be likened to a latent time bomb, poised to detonate. Nevertheless, amidst this conundrum, there arises a glimmer of hope - a beacon of potential progress in our quest for healthier hearts. New Insight: The Burden of Economic Costs Beyond the formidable health challenges posed by hypertension in India, there is an additional layer of concern that often remains obscured. The economic toll imposed by this silent epidemic is substantial. A study conducted by the Indian Heart Association estimated that the direct and indirect costs of treating hypertension in India amounted to a staggering 30 billion dollars annually. These costs encompass medical expenses, lost productivity, and the financial burden on families affected by hypertension-related complications. Thus, in our pursuit of mitigating the effects of hypertension, we are also confronted with the imperative need to alleviate its profound economic impact. NMN: A Ray of Hope for Hypertension Patients A recent study published in Signal Transduction and Target Therapy has set the scientific community buzzing with excitement. Led by Tao and associates from the First Affiliated Hospital of Sun Yat-sen University in China, this investigation has elucidated the promise of Nicotinamide Mononucleotide (NMN) as a paradigm-shifting remedy for hypertension. Unveiling the Power of NMN The researchers began by studying 19 adults aged 18 to 80, all dealing with mild hypertension. These individuals underwent lifestyle changes, including adopting a low-salt, high-fiber diet and engaging in regular aerobic exercise. However, the real breakthrough came when nine of them supplemented their lifestyle changes with 800 mg of NMN daily for six weeks, while the remaining 10 participants relied solely on lifestyle modifications. The results were nothing short of astounding. The group taking NMN showed a significant drop in systolic blood pressure, a crucial indicator of hypertensive blood pressure. This discovery suggests that NMN can genuinely help lower blood pressure in people with hypertension. Unlocking the NAD+ Connection To unravel the underlying mechanisms at play, Tao and colleagues delved deep into the world of cellular biology. They uncovered that hypertension patients had significantly lower levels of blood cell NAD+ compared to healthy adults. However, when NMN was introduced alongside lifestyle changes, NAD+ levels in hypertensive patients shot up by approximately 43%. This incredible finding indicates that NMN might have the potential to restore NAD+ levels in hypertension patients. But the story doesn't end there. The researchers also explored the role of the NAD+ consuming enzyme CD38 in endothelial cells. Surprisingly, they found that CD38 levels were over twice as high in hypertension patients compared to their healthy counterparts. This increased CD38 activity appears to be a contributing factor to the lower NAD+ levels in hypertension patients. Consequently, inhibiting CD38 could be a promising avenue for increasing NAD+ levels and mitigating high blood pressure. A New Dawn for Hypertension Treatment In the words of Tao and colleagues, "Hypertension is recognized as an age-related disease, and NAD+ supplementation may be a promising clinical strategy as an aging-targeted intervention for hypertension." This study presents the first human trial evidence showing that NMN can effectively lower blood pressure in patients with hypertension. Furthermore, it sheds light on the previously unexplored connection between falling NAD+ levels and hypertension. The implications of this research are profound. NMN, known for its safety profile, may hold the key to transforming hypertension treatment. Additionally, the study suggests that CD38 inhibitors, like the pharmaceutical agent 78c, could play a pivotal role in hypertension management in the future, although they are currently available only for laboratory use. As we grapple with the increasing surge of hypertension in India and globally, the research carried out by Tao and colleagues presents a glimmer of optimism. The potential of NMN to diminish blood pressure and reinstate NAD+ levels in individuals with hypertension is a hopeful stride towards more efficient treatments. While additional investigation is essential, these discoveries have unveiled fresh pathways for addressing this silent threat and enhancing the well-being of millions. In conclusion, elevated blood pressure poses a critical health concern in India, impacting individuals across all age brackets, including the younger generation. The pioneering exploration into NMN's influence on hypertension sparks a glint of optimism for superior hypertension management. With sustained research and inventive solutions, we stand at the brink of a new era in the battle against hypertension, with the potential to save numerous lives.
Learn more
The Protein Intake Sweet Spot For Maximizing Metabolic Healthspan and Lifespan. Japanese Study Reveals Key Info
Protein Ratio For A Longer Life Did you know that low-protein diets have actually been found to extend the lifespan of rodents? That's got us thinking about potential benefits for us humans too. But reducing protein intake might have its downsides too. We're talking about compromising our overall quality of life here. You see when we don't get enough protein, it can actually worsen age-related muscle loss, which is known as sarcopenia. And trust us, sarcopenia can be a real problem, causing mobility and strength issues that mess with our independence. Not to mention the increased risk of falls and fractures. Ouch! The optimal balance of nutrition for ideal health outcomes may vary across different life stages So, finding the right balance in protein intake becomes crucial. Researchers from the Tokyo Metropolitan Institute of Gerontology in Japan did an intensive study with mice to figure out the optimal protein intake for metabolic health and muscle preservation. Their findings, published in GeroScience, revealed that a protein intake of around 35% was the sweet spot for maintaining the metabolic health of those middle-aged mice.Dr. Yoshitaka Kondo, the lead author, had some interesting insights to share. He said, “The optimal balance of macronutrients for ideal health outcomes may vary across different life stages. Previous studies show the possibility of minimizing age-specific mortality throughout life by changing the ratio of dietary protein to carbohydrates during the approach to old age in mice. However, the amount of protein that should be consumed to maintain metabolic health while approaching old age is still unclear.”The study showed that protein intake didn't have a significant impact on total muscle mass. However, here's the kicker—strength wasn't actually evaluated. So, we can't say for sure if low protein intake leads to sarcopenia in this context. So it’s still a bit of a mystery.Now let's talk about those naughty fat cells in the liver. When they start piling up, it can lead to liver damage and raise the risk of some serious conditions like diabetes, heart attacks, and strokes. Not good news, right? Well, those middle-aged mice in the study had higher levels of liver fat compared to their younger counterparts. But hold your horses, when their protein intake went beyond 25% (in the P25, P35, and P45 groups), boom! The liver fat took a nosedive. So, it seems like a moderate amount of protein can keep that liver fat buildup in check, especially when we hit middle age. The magic number seems to be 35% for reducing blood glucose levels. And let's not forget about blood glucose levels, the troublemakers behind diabetes, and other nasty stuff. The study uncovered something interesting—middle-aged mice actually had lower blood glucose levels than their younger pals. And here's the kicker again, a protein intake of 35% resulted in even lower blood glucose levels compared to levels below 35%. But hey, don't go crazy with the protein party because a protein intake of 45% seemed to raise those blood glucose levels. So, the magic number here seems to be 35% for reducing blood glucose levels.Now, we can't ignore those pesky free fatty acids that mess with our insulin resistance and contribute to high blood glucose levels. You guessed it, those middle-aged mice had higher levels of those bad boys floating around compared to the youngsters. A protein intake of 45% seemed to boost those levels even more. So, when we consider all the evidence, it looks like a protein intake level of around 35% is the ticket to optimize liver fat content, blood glucose, and those naughty free fatty acids.To sum it all up, the findings from Dr. Kondo and the gang suggest that a protein intake of roughly 35% can work wonders for our metabolic health and put the brakes on metabolic aging. Since metabolic issues are linked to some seriously nasty diseases, it's safe to say that chowing down on moderate amounts of protein might just extend our precious time on this planet. We still don't have the full scoop on how protein intake affects muscle strength and that sarcopenia thing. So, let's keep our eyes peeled for more research to figure out the ideal protein intake for different age groups.Dr. Kondo has some words of wisdom for us too. He says, “Protein requirements change through the course of life, being higher in younger reproductive mice, reducing through middle age, and rising again in older mice as protein efficiency declines. The same pattern is likely to be observed in humans. Therefore, it could be assumed that increasing daily protein intake in meals could promote metabolic health of people. Moreover, ideal dietary macronutrient balance at each life stage could also extend health span.” How to optimize macronutrients? And here's the fun part—the percentage of protein intake is determined by our total caloric intake. So, let's say we're rocking a 1,700-calorie diet. Our protein intake would be around 23.5% (yup, it's all about dividing [1,700 total calories / 800 calories from protein] x 100). Now, to figure out your daily protein, fat, and carb intake, you've got to keep track of those grams for every bite you take. It can be a bit of a chore, but fear not! There are nifty smartphone apps like My Fitness Pal that make the whole process a breeze.So, there you have it—protein, fats, carbs, and a dash of science to keep us informed about the magical world of longevity. Stay healthy and rock that well-balanced plate, folks!
Learn more
NMN Improves Diabetes-Induced Male Infertility, New Study Suggests
By the year 2045, approximately 10% of the world's population is alarmingly estimated to have type II diabetes. Men with diabetes often have fertility problems, including reduced sex drive, difficulty getting erections, and abnormal sperm. While some medications like pioglitazone and metformin have shown potential in improving sperm function, better treatments are needed to address male infertility in diabetic individuals. A study conducted by researchers from the University of South China found that giving diabetic male mice a substance called nicotinamide mononucleotide (NMN) improved the structure and function of their testes, leading to more healthy and viable sperm. The researchers observed that NMN also restored the size of the tubes in the testes responsible for creating sperm and increased the number of essential enzymes involved in using glucose for energy, which improved the overall health of the testes. These findings suggest that NMN could potentially reverse male infertility caused by diabetes. NMN Counteracts Diabetes-Linked Testicular Dysfunction During the study, the researchers induced diabetes in mice using a drug called streptozotocin, which led to a significant reduction in the number of sperm and an increase in the proportion of abnormal sperm. However, when the mice received NMN treatment, these negative effects were reversed, with the sperm count returning to normal and the amount of abnormal sperm decreasing. To further understand NMN's impact on the testes, the researchers examined the size of specific structures called seminiferous tubules, where sperm precursor cells are made. The mice with diabetes had smaller seminiferous tubules compared to the ones without diabetes. When given NMN, those tubules bounced back to a healthier size. It looks like NMN might be onto something here in reversing the effects of diabetes on these important structures. This suggests that NMN's ability to improve the structure of the testes could potentially reverse infertility caused by diabetes. Type II diabetes affects the way the body uses glucose for energy. To investigate how NMN might be working, the researchers looked at the levels of important enzymes involved in this process in the testes of diabetic mice. They found that the enzyme levels were significantly reduced due to diabetes, but when NMN was given, they increased again. This suggests that NMN may help the testes use glucose properly, providing the energy needed for producing sperm and potentially reversing infertility. The Diabetic Problem in India India is grappling with a significant diabetes problem, with approximately 77 million people already diagnosed with the condition. In 2020 alone, around 700,000 Indians lost their lives due to diabetes and its complications. Shockingly, this number is expected to skyrocket to a staggering 134 million diabetes cases in India by the year 2045. The increase in diabetes cases can be directly linked to various changes in the environment and lifestyle. Urbanization has brought about significant shifts in how people live and eat, leading to unhealthy dietary habits and a rise in obesity rates. To make matters worse, there's a surge in the accumulation of visceral fat, which poses additional health risks. Research indicates that Indians have a higher tendency for insulin resistance, a condition where the body doesn't respond well to insulin, increasing the risk of diabetes. All these factors combined make Indians more susceptible to developing diabetes, creating a challenging health crisis in the country. Overcoming Diabetes-Related Male Infertility Medications like pioglitazone and metformin may help restore fertility in men with diabetes by improving glucose usage in the testes. The study's findings suggest that NMN could offer another potential solution for restoring male fertility in diabetic individuals. Further research should compare the effectiveness of pioglitazone, metformin, and NMN in this regard. Adopting healthier eating habits and regular exercise can also help counter the effects of diabetes and possibly restore male fertility. The discovery that NMN might restore fertility in diabetic men brings hope for those of reproductive age, giving them the possibility of having children in the future.
Learn more
NMN: Is It A Game-Changer For Diabetes In India?
Diabetes! It's a very real chronic condition that messes with your body's insulin production or usage, causing those sugar levels to go haywire. And that’s very bad news for your nerves and blood vessels. 77 million adults battling type 2 diabetes In India Now, let's shift our focus to India, where we're looking at a mind-boggling number of 77 million adults battling type 2 diabetes. And that's not all, there are an additional 25 million folks who are just teetering on the edge with prediabetes. But here's the kicker: more than half of these poor souls have no clue they're in the diabetes danger zone. That's a recipe for disaster in itself, as they're at serious risk of heart attacks, strokes, nerve damage, foot ulcers, infections, going blind (yep, retinopathy), and having all sorts of kidney problems.But hey, there's a way to handle diabetes, and it involves getting your insulin sensitivity game on point. It's all about embracing a healthy lifestyle, you know? Catch enough Zzzs, get that body moving with some regular exercise, keep those stress levels in check, watch your weight, load up on fiber-rich fruits and veggies, make wise choices when it comes to carbs by opting for low-glycemic goodies, and for the love of all things sweet, cut back on the sugary treats. NMN might be the key to improving insulin sensitivity Alright, now it's time to dive into the fascinating world of NMN (Nicotinamide mononucleotide). NMN is like the primary building block for our DNA, the backbone of our body's operations. Once it sneaks its way into our cells, it transforms into a superhero called Nicotinamide Adenine Dinucleotide (NAD). This NAD character pulls off some seriously vital tasks like repairing DNA, managing gene expression, handling stress, and producing energy like a champ.Here's where it gets juicy: NMN might just be the key to improving insulin sensitivity. A recent study on ladies with prediabetes and some extra pounds showed some fantastic results from NMN supplementation. It revved up their metabolism, made them more sensitive to insulin, and put them on the right track to better health. How? Well, NMN gets those NAD levels up, giving insulin the power boost it needs to handle that pesky glucose and improve insulin sensitivity.While studies on animals have shown some promising signs of NMN, we can't jump the gun just yet. We still need those human clinical trials to get the real scoop. One animal study on diabetes showed that NMN didn't have a significant impact on glucose tolerance, insulin levels, or insulin resistance. However, it did hint at some potential protection against diabetic neuropathy, which is nerve damage that often tags along with diabetes. These animal studies give us a general idea of the safety and effectiveness of NMN, but we need more research on real-life humans to unlock its true potential for people with diabetes.
Learn more